Cargando…
Prognostic Value of Serum Caspase-Cleaved Cytokeratin-18 Levels before Liver Transplantation for One-Year Survival of Patients with Hepatocellular Carcinoma
Cytokeratin (CK)-18 is the major intermediate filament protein in the liver and during hepatocyte apoptosis is cleaved by the action of caspases; the resulting fragments are released into the blood as caspase-cleaved cytokeratin (CCCK)-18. Higher circulating levels of CCCK-18 have been found in pati...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5037799/ https://www.ncbi.nlm.nih.gov/pubmed/27618033 http://dx.doi.org/10.3390/ijms17091524 |
_version_ | 1782455816682471424 |
---|---|
author | Lorente, Leonardo Rodriguez, Sergio T. Sanz, Pablo Pérez-Cejas, Antonia Padilla, Javier Díaz, Dácil González, Antonio Martín, María M. Jiménez, Alejandro Barrera, Manuel A. |
author_facet | Lorente, Leonardo Rodriguez, Sergio T. Sanz, Pablo Pérez-Cejas, Antonia Padilla, Javier Díaz, Dácil González, Antonio Martín, María M. Jiménez, Alejandro Barrera, Manuel A. |
author_sort | Lorente, Leonardo |
collection | PubMed |
description | Cytokeratin (CK)-18 is the major intermediate filament protein in the liver and during hepatocyte apoptosis is cleaved by the action of caspases; the resulting fragments are released into the blood as caspase-cleaved cytokeratin (CCCK)-18. Higher circulating levels of CCCK-18 have been found in patients with hepatocellular carcinoma (HCC) than in healthy controls and than in cirrhotic patients. However, it is unknown whether serum CCCK-18 levels before liver transplantation (LT) in patients with HCC could be used as a prognostic biomarker of one-year survival, and this was the objective of our study with 135 patients. At one year after LT, non-survivors showed higher serum CCCK-18 levels than survivors (p = 0.001). On binary logistic regression analysis, serum CCCK-18 levels >384 U/L were associated with death at one year (odds ratio = 19.801; 95% confidence interval = 5.301–73.972; p < 0.001) after controlling for deceased donor age. The area under the receiver operating characteristic (ROC) curve of serum CCCK-18 levels to predict death at one year was 77% (95% CI = 69%–84%; p < 0.001). The new finding of our study was that serum levels of CCCK-18 before LT in patients with HCC could be used as prognostic biomarker of survival. |
format | Online Article Text |
id | pubmed-5037799 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-50377992016-09-29 Prognostic Value of Serum Caspase-Cleaved Cytokeratin-18 Levels before Liver Transplantation for One-Year Survival of Patients with Hepatocellular Carcinoma Lorente, Leonardo Rodriguez, Sergio T. Sanz, Pablo Pérez-Cejas, Antonia Padilla, Javier Díaz, Dácil González, Antonio Martín, María M. Jiménez, Alejandro Barrera, Manuel A. Int J Mol Sci Brief Report Cytokeratin (CK)-18 is the major intermediate filament protein in the liver and during hepatocyte apoptosis is cleaved by the action of caspases; the resulting fragments are released into the blood as caspase-cleaved cytokeratin (CCCK)-18. Higher circulating levels of CCCK-18 have been found in patients with hepatocellular carcinoma (HCC) than in healthy controls and than in cirrhotic patients. However, it is unknown whether serum CCCK-18 levels before liver transplantation (LT) in patients with HCC could be used as a prognostic biomarker of one-year survival, and this was the objective of our study with 135 patients. At one year after LT, non-survivors showed higher serum CCCK-18 levels than survivors (p = 0.001). On binary logistic regression analysis, serum CCCK-18 levels >384 U/L were associated with death at one year (odds ratio = 19.801; 95% confidence interval = 5.301–73.972; p < 0.001) after controlling for deceased donor age. The area under the receiver operating characteristic (ROC) curve of serum CCCK-18 levels to predict death at one year was 77% (95% CI = 69%–84%; p < 0.001). The new finding of our study was that serum levels of CCCK-18 before LT in patients with HCC could be used as prognostic biomarker of survival. MDPI 2016-09-09 /pmc/articles/PMC5037799/ /pubmed/27618033 http://dx.doi.org/10.3390/ijms17091524 Text en © 2016 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC-BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Brief Report Lorente, Leonardo Rodriguez, Sergio T. Sanz, Pablo Pérez-Cejas, Antonia Padilla, Javier Díaz, Dácil González, Antonio Martín, María M. Jiménez, Alejandro Barrera, Manuel A. Prognostic Value of Serum Caspase-Cleaved Cytokeratin-18 Levels before Liver Transplantation for One-Year Survival of Patients with Hepatocellular Carcinoma |
title | Prognostic Value of Serum Caspase-Cleaved Cytokeratin-18 Levels before Liver Transplantation for One-Year Survival of Patients with Hepatocellular Carcinoma |
title_full | Prognostic Value of Serum Caspase-Cleaved Cytokeratin-18 Levels before Liver Transplantation for One-Year Survival of Patients with Hepatocellular Carcinoma |
title_fullStr | Prognostic Value of Serum Caspase-Cleaved Cytokeratin-18 Levels before Liver Transplantation for One-Year Survival of Patients with Hepatocellular Carcinoma |
title_full_unstemmed | Prognostic Value of Serum Caspase-Cleaved Cytokeratin-18 Levels before Liver Transplantation for One-Year Survival of Patients with Hepatocellular Carcinoma |
title_short | Prognostic Value of Serum Caspase-Cleaved Cytokeratin-18 Levels before Liver Transplantation for One-Year Survival of Patients with Hepatocellular Carcinoma |
title_sort | prognostic value of serum caspase-cleaved cytokeratin-18 levels before liver transplantation for one-year survival of patients with hepatocellular carcinoma |
topic | Brief Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5037799/ https://www.ncbi.nlm.nih.gov/pubmed/27618033 http://dx.doi.org/10.3390/ijms17091524 |
work_keys_str_mv | AT lorenteleonardo prognosticvalueofserumcaspasecleavedcytokeratin18levelsbeforelivertransplantationforoneyearsurvivalofpatientswithhepatocellularcarcinoma AT rodriguezsergiot prognosticvalueofserumcaspasecleavedcytokeratin18levelsbeforelivertransplantationforoneyearsurvivalofpatientswithhepatocellularcarcinoma AT sanzpablo prognosticvalueofserumcaspasecleavedcytokeratin18levelsbeforelivertransplantationforoneyearsurvivalofpatientswithhepatocellularcarcinoma AT perezcejasantonia prognosticvalueofserumcaspasecleavedcytokeratin18levelsbeforelivertransplantationforoneyearsurvivalofpatientswithhepatocellularcarcinoma AT padillajavier prognosticvalueofserumcaspasecleavedcytokeratin18levelsbeforelivertransplantationforoneyearsurvivalofpatientswithhepatocellularcarcinoma AT diazdacil prognosticvalueofserumcaspasecleavedcytokeratin18levelsbeforelivertransplantationforoneyearsurvivalofpatientswithhepatocellularcarcinoma AT gonzalezantonio prognosticvalueofserumcaspasecleavedcytokeratin18levelsbeforelivertransplantationforoneyearsurvivalofpatientswithhepatocellularcarcinoma AT martinmariam prognosticvalueofserumcaspasecleavedcytokeratin18levelsbeforelivertransplantationforoneyearsurvivalofpatientswithhepatocellularcarcinoma AT jimenezalejandro prognosticvalueofserumcaspasecleavedcytokeratin18levelsbeforelivertransplantationforoneyearsurvivalofpatientswithhepatocellularcarcinoma AT barreramanuela prognosticvalueofserumcaspasecleavedcytokeratin18levelsbeforelivertransplantationforoneyearsurvivalofpatientswithhepatocellularcarcinoma |